Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Y Lim

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Blood Advances|October 2, 2020
Inhibitors and mortality in persons with nonsevere hemophilia A in the United StatesMing Y Lim, Dunlei Cheng, Michael Recht, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 17, 2022
Pregnancy and childbirth in women with bleeding disorders: A retrospective cohort studyAshli Young, Ming Y Lim, Jessica Sanders, et al.
American Journal of Hematology|September 25, 2020
Management of inhibitors in persons with non-severe hemophilia A in the United StatesMing Y Lim, Dunlei Cheng, Michael Recht, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 28, 2021
Daratumumab as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathyVinay Mathew Thomas, Jeffrey A Gilreath, Shawn Newton, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 19, 2021
How to Choose An Appropriate Anticoagulant for Cancer-Associated ThrombosisJordan K Schaefer, Amro Elshoury, Victoria R Nachar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 21, 2022
Update on Guidelines for the Prevention of Cancer-Associated ThrombosisAmro Elshoury, Jordan K Schaefer, Ming Y Lim, et al.
Value in Health Regional Issues|November 20, 2021
Budget Impact of Emicizumab for Routine Prophylaxis of Bleeding Episodes in Patients With Hemophilia A With InhibitorsAlexandre Hikiji Watanabe, Shaun Wen Huey Lee, Chatree Chai-Adisaksopha, et al.
Leukemia & Lymphoma|February 4, 2015
Lenalidomide-associated hemolytic anemiaMing Y Lim, Jay S Raval, Kristy L Richards, et al.
European Journal of Haematology|March 19, 2015
Importance of pharmacokinetic studies in the management of acquired factor X deficiencyMing Y Lim, Timothy McCarthy, Sheh-Li Chen, et al.
Research and Practice in Thrombosis and Haemostasis|June 16, 2025
Identifying and addressing underuse in hematologic care through systems-based hematologyJacob C Cogan, Allison E Burnett, Alexandra Power-Hays, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Blood Advances|October 2, 2020
Inhibitors and mortality in persons with nonsevere hemophilia A in the United StatesMing Y Lim, Dunlei Cheng, Michael Recht, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 17, 2022
Pregnancy and childbirth in women with bleeding disorders: A retrospective cohort studyAshli Young, Ming Y Lim, Jessica Sanders, et al.
American Journal of Hematology|September 25, 2020
Management of inhibitors in persons with non-severe hemophilia A in the United StatesMing Y Lim, Dunlei Cheng, Michael Recht, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 28, 2021
Daratumumab as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathyVinay Mathew Thomas, Jeffrey A Gilreath, Shawn Newton, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 19, 2021
How to Choose An Appropriate Anticoagulant for Cancer-Associated ThrombosisJordan K Schaefer, Amro Elshoury, Victoria R Nachar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 21, 2022
Update on Guidelines for the Prevention of Cancer-Associated ThrombosisAmro Elshoury, Jordan K Schaefer, Ming Y Lim, et al.
Value in Health Regional Issues|November 20, 2021
Budget Impact of Emicizumab for Routine Prophylaxis of Bleeding Episodes in Patients With Hemophilia A With InhibitorsAlexandre Hikiji Watanabe, Shaun Wen Huey Lee, Chatree Chai-Adisaksopha, et al.
Leukemia & Lymphoma|February 4, 2015
Lenalidomide-associated hemolytic anemiaMing Y Lim, Jay S Raval, Kristy L Richards, et al.
European Journal of Haematology|March 19, 2015
Importance of pharmacokinetic studies in the management of acquired factor X deficiencyMing Y Lim, Timothy McCarthy, Sheh-Li Chen, et al.
Research and Practice in Thrombosis and Haemostasis|June 16, 2025
Identifying and addressing underuse in hematologic care through systems-based hematologyJacob C Cogan, Allison E Burnett, Alexandra Power-Hays, et al.
Pageof 9